WebbBiosimilar Drug Profile: Nivestym is a biosimilar version of filgrastim (reference product, Neupogen, Amgen) manufactured and marketed by Pfizer. Originally designated PF … WebbA biologic is a medicine that is made in a living system, such as yeast, bacteria, or animal cells. A biosimilar is a medicine that is very close in structure and function to a specific biologic medicine (also known as the reference product).The biosimilar has a structure that is highly similar to, but not exactly the same as, the brand name biologic
HIGHLIGHTS OF PRESCRIBING INFORMATION - Pfizer
WebbNivestym: Filgrastim belongs to the family of medications known as granulocyte colony stimulating factors ... This medication may be available under multiple brand names and/or in several different forms. Any specific brand name of this medication may not be available in all of the forms or approved for all of the conditions discussed here. Webb1 feb. 2024 · US Brand Name. Neupogen; Nivestym; Zarxio; Descriptions. Filgrastim injection is used to treat neutropenia (low white blood cells) that is caused by cancer medicines. It is a synthetic (man-made) form of a substance that is naturally produced in your body called a colony stimulating factor. Filgrastim helps the bone marrow to make … hdc healthy
Second Biosimilar Approved to Treat Neutropenia - AJMC
WebbFor diagnosis of peginterferon-related neutropenia and request for Neupogen (off-label), Nivestym (off-label), Releuko (off-label), or Zarxio ... Additional Information: The FDA defines biosimilar as a biological product that is highly similar to and has no clinically meaningful differences from an existing FDA-approved reference product. WebbSearch New Search. Search in Table. Products Found: 13. DIN/NPN/ PIN Generic Name Product Name, Strength & Dosage Form Unit Price, Unit of Issue Manufacturer LCA Price ... Product Name, Strength & Dosage Form: NIVESTYM (0.8 ML SYRINGE) 0.3 MG / SYR INJECTION SYRINGE: Unit Price, Unit of Issue: 230.9000: Manufacturer: PFI: LCA … WebbFilgrastim injection products come as a solution (liquid) in vials and prefilled syringes to be injected subcutaneously (under the skin) or to be slowly or continuously injected intravenously (into a vein). It is usually given once a day, but filgrastim injection products (Neupogen, Nivestym, Releuko, Zarxio) may be given twice a day when it is ... hdch endocrinology